Answers are grounded in this paper and cite their sources.
The diagnosis and management of tumors commences with histopathology using routine staining procedures followed by immunohistochemical techniques in which certain biochemical indicators -the tumor markers are utilized. Each subcellular component can produce markers in the form of glycoproteins, antigens, receptors, hormones, enzymes, proteomic elements and genomic factors. The ongoing research has introduced numerous new markers to the extensive existing data; thereby necessitating the urgent need to categorize these biomarkers. This review presents a classification of currently and commonly used novel markers in various head and neck malignancies. Relevant indexed articles were referred for each clinically significant marker being considered for evaluation. The markers demonstrating potential impact on diagnosis, prognosis or treatment of the tumor, pertaining to head and neck region have been included for the review and segregated as per consensus of all the authors for the under mentioned.
No takes yet. Share an insight, caveat, or question.
Jhamb et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: